Publications:

Bacteria-derived chimeric toxins as potential anticancer agents.

Frontiers In Oncology

Khoshnood, Saeed S; Fathizadeh, Hadis H; Neamati, Foroogh F; Negahdari, Babak B; Baindara, Piyush P; Abdullah, Mohd Azmuddin MA; Haddadi, Mohammad Hossein MH

Publication Date: 2022

Variant appearance in text: EGFR: R427A

PubMed Link: 36158673

Variant Present in the following documents:

• Main text
• fonc-12-953678.pdf

View BVdb publication page

Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors.

Biomolecules

Hagerty, Brendan L BL; Pegna, Guillaume J GJ; Xu, Jian J; Tai, Chin-Hsien CH; Alewine, Christine C

Publication Date: 2020-06-28

Variant appearance in text: EGFR: R427A

PubMed Link: 32605175

Variant Present in the following documents:

• Main text
• biomolecules-10-00973.pdf

View BVdb publication page

HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution.

Pharmaceutics

Ding, Haozhong H; Altai, Mohamed M; Yin, Wen W; Lindbo, Sarah S; Liu, Hao H; Garousi, Javad J; Xu, Tianqi T; Orlova, Anna A; Tolmachev, Vladimir V; Hober, Sophia S; Gräslund, Torbjörn T

Publication Date: 2020-04-24

Variant appearance in text: EGFR: R427A

PubMed Link: 32344762

Variant Present in the following documents:

• Main text
• pharmaceutics-12-00391.pdf

View BVdb publication page